Search company, investor...

Executives

5

Board of Directors

2

Endologix Management Team

5 Team Members

Endologix has 5 executives. Endologix's former Chief Executive Officer is John McDermott.

Name

Work History

Title

Status

John McDermott

Chief Executive Officer

Former

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

John McDermott

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Former

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Endologix Board of Directors

2 Board of directors

Endologix has 2 board of directors, including Guido Neels.

Name

Firm

Work History

Other Seats

Guido Neels

Guido Neels has over 35 years of experience developing international healthcare businesses. From May 2004 until retiring in November 2005, Mr. Neels served as Chief Operating Officer of Guidant Corporation, a world leader in the development of cardiovascular medical products, where he was responsible for the global operations of Guidant’s four operating units - Cardiac Rhythm Management, Vascular Intervention, Cardiac Surgery, and Endovascular Solutions. From December 2002 to May 2004, he was Group Chairman, Office of the President at Guidant, responsible for worldwide sales operations, corporate communications, corporate marketing, investor relations and government relations. From January 2000 to December 2002, he was President of Guidant for Europe, Middle East, Africa and Canada. He previously served as Vice President of Global Marketing for Vascular Intervention and as Managing Director for German and Central European operations. From 1982 to 1994, until Guidant was spun off as an independent public company from Eli Lilly and Co., Mr. Neels held general management, sales and marketing positions at Lilly in the U.S. and Europe. From 1972 to 1980, he held positions in information technology, finance and manufacturing at Raychem Corporation in Belgium and the U.S. Mr. Neels serves as the Chairman of the Board of Directors for Oraya Therapeutics, and serves on the Board of Directors for Entellus Medical, ClearVascular, Endologix and Bioventus. In addition to the portfolio company boards on which he serves, Mr. Neels also serves on the Board of Directors for Arsenal Medical, EndGenitor Technologies and Christel House International. Mr. Neels joined Essex Woodlands as a Partner in August 2006 and was promoted to Managing Director in 2008.

Endologix

John McDermott

President, Bard Peripheral Vascular, C.R. Bard Inc.

Endologix

Name

Guido Neels

John McDermott

Firm

Work History

Guido Neels has over 35 years of experience developing international healthcare businesses. From May 2004 until retiring in November 2005, Mr. Neels served as Chief Operating Officer of Guidant Corporation, a world leader in the development of cardiovascular medical products, where he was responsible for the global operations of Guidant’s four operating units - Cardiac Rhythm Management, Vascular Intervention, Cardiac Surgery, and Endovascular Solutions. From December 2002 to May 2004, he was Group Chairman, Office of the President at Guidant, responsible for worldwide sales operations, corporate communications, corporate marketing, investor relations and government relations. From January 2000 to December 2002, he was President of Guidant for Europe, Middle East, Africa and Canada. He previously served as Vice President of Global Marketing for Vascular Intervention and as Managing Director for German and Central European operations. From 1982 to 1994, until Guidant was spun off as an independent public company from Eli Lilly and Co., Mr. Neels held general management, sales and marketing positions at Lilly in the U.S. and Europe. From 1972 to 1980, he held positions in information technology, finance and manufacturing at Raychem Corporation in Belgium and the U.S. Mr. Neels serves as the Chairman of the Board of Directors for Oraya Therapeutics, and serves on the Board of Directors for Entellus Medical, ClearVascular, Endologix and Bioventus. In addition to the portfolio company boards on which he serves, Mr. Neels also serves on the Board of Directors for Arsenal Medical, EndGenitor Technologies and Christel House International. Mr. Neels joined Essex Woodlands as a Partner in August 2006 and was promoted to Managing Director in 2008.

President, Bard Peripheral Vascular, C.R. Bard Inc.

Other Seats

Endologix

Endologix

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Endologix to Competitors

V
Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

T
TriReme Medical

TriReme Medical is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The company is focused on the US and the emerging Asian markets.

I
Intersect Partners

Intersect Partners specializes in transforming innovative ideas into medical products within the healthcare sector. They offer services that guide concepts through the development process to become market-ready medical solutions. It is based in San Clemente, California.

D
DuoCore

DuoCure offers intraluminal minimally invasive implantable device for treatment of obesity.

N
Neocrin

Researcher and developer of a minimally invasive, encapsulated cellular transplant device for the treatment of diabetes. The company sold its assets to Novocell.

Monteris Medical Logo
Monteris Medical

Monteris Medical is a neurosurgical company that operates in the healthcare industry. The company offers a minimally invasive, robotically controlled laser thermal therapy system that uses MRI-guided laser light to destroy unwanted tissue in the brain, such as tumors and lesions. Monteris primarily serves the healthcare sector, particularly neurosurgery. It was founded in 1999 and is based in Hopkins, Minnesota.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.